USA
Cours de l'action
95.79 €
Lipiodol®
Guerbet has acquired the Ethiodol® NDA from Nycomed US Inc. effective May 7, 2010 and is working with the FDA to resume manufacturing of Ethiodol® in the near future to ensure continued availability for the US patients.
Accreditation
Sales Representative
To find your local Medical Center Professional, please enter your zip code: